ES2084576T3 - Vacuna contra la coccidiosis. - Google Patents

Vacuna contra la coccidiosis.

Info

Publication number
ES2084576T3
ES2084576T3 ES87111820T ES87111820T ES2084576T3 ES 2084576 T3 ES2084576 T3 ES 2084576T3 ES 87111820 T ES87111820 T ES 87111820T ES 87111820 T ES87111820 T ES 87111820T ES 2084576 T3 ES2084576 T3 ES 2084576T3
Authority
ES
Spain
Prior art keywords
gametocytes
eimeria
vaccine against
extract
against coccidiosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87111820T
Other languages
English (en)
Inventor
Michael Wallach
Thea Pugatsch
David Mencher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chilwalner
Original Assignee
Chilwalner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chilwalner filed Critical Chilwalner
Application granted granted Critical
Publication of ES2084576T3 publication Critical patent/ES2084576T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE HAN PREPARADO GAMETOCITOS DE EIMERIA MAXIMA SUSTANCIALMENTE PURIFICADOS Y SE DESCRIBEN METODOS PARA SU PREPARACION. UN EXTRACTO PROTEINICO DERIVADO DE LOS GAMETOCITOS COMPRENDE POR LO MENOS 9 PROTEINAS DE PESOS MOLECULARES VARIABLES. LAS VACUNAS PARA CONFERIR A UN POLLO UNA INMUNIDAD ACTIVA CONTRA LA INFECCION COMPRENDE UNA CANTIDAD DE GAMETOCITOS DE EIMERIA MAXIMA O DE EXTRACTO DE GAMETOCITOS EFICAZ PARA LA INMUNIZACION, Y UN PORTADOR. TAMBIEN SE PROPORCIONA UN METODO DE DESARROLLO IN VITRO DE GAMETOCITOS U OOCISTOS DE EIMERIA SPP Y UN METODO DE ANALIZAR LA EFICACIA DEL FARMACO O DEL ANTICUERPO ANTIGAMETOCITO SOBRE EL DESARROLLO IN VITRO DE LA EIMERIA SPP.
ES87111820T 1986-08-14 1987-08-14 Vacuna contra la coccidiosis. Expired - Lifetime ES2084576T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89661186A 1986-08-14 1986-08-14

Publications (1)

Publication Number Publication Date
ES2084576T3 true ES2084576T3 (es) 1996-05-16

Family

ID=25406502

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87111820T Expired - Lifetime ES2084576T3 (es) 1986-08-14 1987-08-14 Vacuna contra la coccidiosis.

Country Status (10)

Country Link
EP (1) EP0256536B1 (es)
JP (3) JP2617946B2 (es)
AT (1) ATE132754T1 (es)
AU (1) AU633244B2 (es)
CA (1) CA1340838C (es)
DE (1) DE3751670T2 (es)
ES (1) ES2084576T3 (es)
GR (1) GR3019619T3 (es)
IL (2) IL83523A (es)
ZA (1) ZA876027B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
NZ232372A (en) * 1989-02-10 1993-04-28 Merck & Co Inc Glycolipid-linked membrane-associated immunogens of eimeria useful in immunising poultry against coccidiosis
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
NZ272945A (en) * 1994-09-16 1997-12-19 Akzo Nobel Nv Eimeria t-lymphocyte stimulating protein and coding sequence, its production and use
DE19828322A1 (de) * 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
NZ500033A (en) * 1998-10-07 2001-06-29 Akzo Nobel Nv Hydrophilic eimeria polypeptides for use as coccidiosis vaccines
ZA200400479B (en) 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
CN100348608C (zh) 2001-07-06 2007-11-14 Abic特瓦生物实验室有限公司 编码重组的来源于巨型艾美球虫子孢子/裂殖子的250kDa抗原的核酸,和它们的应用
WO2015156844A1 (en) * 2014-04-10 2015-10-15 MEP Equine Solutions LLC Method for the quantification of parasite eggs in feces
CN113528348B (zh) * 2021-08-17 2022-04-22 中国农业科学院兰州兽医研究所 一种分离艾美尔球虫小配子的方法和应用
CN114058511A (zh) * 2021-11-30 2022-02-18 中国农业科学院兰州兽医研究所 一种利用dna探针分离球虫小配子的方法
CN117958248A (zh) * 2024-01-29 2024-05-03 中国科学院西北高原生物研究所 一种利用艾美耳球虫防控高原鼠兔的方法
CN118105472A (zh) * 2024-01-30 2024-05-31 南京农业大学 一种巨型艾美耳球虫纳米亚单位疫苗的制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408351A1 (fr) 1977-11-14 1979-06-08 Unilever Nv Procede et composition destines a la lutte contre la coccidiose chez la volaille
EP0135073A3 (en) 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozites of eimeria spp.
EP0135712A3 (en) 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp.
JPS6048924A (ja) 1983-08-24 1985-03-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤
CA1340520C (en) 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix

Also Published As

Publication number Publication date
EP0256536A3 (en) 1989-11-02
JPS63233928A (ja) 1988-09-29
DE3751670T2 (de) 1996-10-24
EP0256536A2 (en) 1988-02-24
EP0256536B1 (en) 1996-01-10
IL108419A0 (en) 1994-04-12
AU7712187A (en) 1988-05-19
IL83523A (en) 1994-10-21
AU633244B2 (en) 1993-01-28
JPH09117282A (ja) 1997-05-06
JPH09118700A (ja) 1997-05-06
ATE132754T1 (de) 1996-01-15
DE3751670D1 (de) 1996-02-22
CA1340838C (en) 1999-12-07
ZA876027B (en) 1988-04-27
JP2769313B2 (ja) 1998-06-25
JP2617946B2 (ja) 1997-06-11
GR3019619T3 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
ES2084576T3 (es) Vacuna contra la coccidiosis.
PT82610B (pt) Processo para a preparacao de tiazolidino-dionas hipoglicemicas
IT8867767A0 (it) Metodo di separazione centrifuga del sangue
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
ES2042058T3 (es) Procedimiento para preparar apoliproteinas a partir de fracciones de plasma sanguineo o suero.
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
EP0283505A4 (en) Vaccine and method of preparation.
ES2104535T1 (es) Vacuna que contiene proteina de membrana externa de bordetella pertussis, y metodo para elaborar tal vacuna.
ES2053460T3 (es) Un procedimiento para recuperar antibioticos glicopeptidicos.
JPS5649323A (en) Coccidiostat
ES2140652T3 (es) Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b.
NL960005I1 (nl) Optisch zuivere verbinding, en werkwijze voor de bereiding daarvan.
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
NZ221379A (en) Nematode plasma membrane-associated protein, extraction method and vaccines containing it
SE8204873D0 (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
OA09037A (en) Prevention and treatement of retroviral disease.
DE69015314D1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
Horton-Smith et al. The development of Eimeria necatrix Johnson, 1930 and Eimeria brunetti Levine, 1942 in the caeca of the domestic fowl (Gallus domesticus)
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
ES2055610T3 (es) Vacuna contra hrsv.
IT8820227A0 (it) Metodo per la sensibilizzazione di piccoli animali all'infezione da virus dell'immunodeficienza umana (hiv)
FI870787A7 (fi) Puhdistettu ihmisen angiogeeninen tekijä, menetelmä sen valmistamiseksi ja farmaseuttisia koostumuksia.
PT85284A (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 256536

Country of ref document: ES